NCT05707910 2026-03-09Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant TumorsWest China HospitalPhase 1 Active not recruiting6 enrolled
NCT06657144 2026-03-02A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsCoherus Oncology, Inc.Phase 1 Recruiting154 enrolled
NCT06283134 2026-01-07A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal CancerChina Medical University, ChinaPhase 1 Not yet recruiting60 enrolled